EMBION’s product launch paves the way to antibiotic-free farming

EMBION Technologies, the provider of plant-based bioactives for the nutrition of the future, has launched its first product PREMBION on the market.…

Embion secures a CHF 250’000 grant

The EPFL spin-off has received a CHF 250’000 grant from Fondation ALCEA, a Swiss public purpose foundation to support its fundraising plans for the…

Swiss microbiome modulation startup looks to investors to scale up

Embion, a novel bioactives developer, has been awarded a grant of CHF250k (US$276k) from a Swiss public purpose fund, Foundation ALCEA, which it says…